Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Paracelsian Inc (PRLN) -- Ignore unavailable to you. Want to Upgrade?

To: Rick Costantino who wrote (4210)	3/24/1999 12:45:00 PM
From: Jonathan Schonsheck	Read Replies (1) \| Respond to of 4342

Threaders - Things are getting serious with BioFIT! Paracelsian Announces Key BioFIT(TM) Appointment ITHACA, N.Y., March 24 /PRNewswire/ -- Paracelsian, Inc. (OTC Bulletin Board: PRLN - news) announced today that Mr. Frank E. Reilly has been appointed to the position of Interim President of its key BioFIT(TM) Functional Testing and Product Development Division. Most recently, Mr. Reilly held the position of Vice President of Global Business Development for Nutrition with R.P. Scherer. ''Mr. Reilly is uniquely qualified to lead Paracelsian's most important core business unit,'' said Bernie Landes, Paracelsian's Chairman, President and CEO. ''Paracelsian's BioFIT(TM) division develops and implements the company's patent pending functional bioassay technology that is essential to the Company's long term success. For that reason, it requires aggressive, experienced leadership,'' continued Mr. Landes. ''We believe that Mr. Reilly's extraordinary Marketing, Sales, Brand Management and International Business Development experience with some of the best managed consumer nutrition and health care companies in the world provides Paracelsian the opportunity for significant appreciation in the Company's value in the future. The fact that we are able to attract a person of such extraordinary capability further underscores our belief in the strength of the BioFIT concept,'' Landes concluded. In the initial period of Mr. Reilly's involvement, during which time he will be satisfying existing commitments, he will gradually take over the management of Paracelsian's BioFIT(TM) division from Chairman and CEO Bernie Landes. After the initial period, it is anticipated that Mr. Reilly's appointment will become permanent. The BioFIT(TM) Division develops and applies functional testing systems for Quality Assurance of botanical products and for the development of Dietary Supplements, OTC preparations, Functional Foods and Nutraceuticals. Mr. Reilly has held senior positions with many of the leading global healthcare companies serving the Dietary Supplement, Prescription and OTC segments of the business. Prior to his most recent position with R.P. Scherer, Mr. Reilly also held the position of Vice President for Marketing and Sales for the HealthCare Division for North America for Nutritional, Prescription and OTC Products. During his tenure many highly successful new Liqui-Gels Branded Products were introduced with some of the largest consumer healthcare and pharmaceutical companies in the world. In addition, Mr. Reilly has had a distinguished career in Brand Management for such well known brands as Alka-Seltzer, Alka-Seltzer Plus Cold Medicine, One a Day Vitamins, Flintstones Vitamins and Bugs Bunny Vitamins for Bayer's Consumer Healthcare Division. Mr. Reilly also held Sales Management positions for Bayer including the responsibility for Wal-Mart, the largest retailer of consumer health care products in the world. Mr. Reilly also held Sales positions with Johnson and Johnson and Nestle Foods prior to coming to Bayer. Mr. Reilly has also served on the Board of the Council of Responsible Nutrition (CRN), the largest trade organization for the dietary supplement industry, for the last several years. ''I am very excited about being a part of the Paracelsian team, as BioFIT is uniquely positioned to capitalize on the growing emphasis on health related products for the aging population worldwide,'' said Mr. Reilly. ''As a former consumer package goods Brand Manager working on some of the largest, most successful and widely known OTC and Nutritional Brands in the world, I realized early on that unique product differentiation is critical to launching successful consumer brands in the market. The BioFIT technology is an excellent vehicle to achieve this objective,'' concluded Mr. Reilly. With Mr. Reilly's appointment, Paracelsian now has appointed Presidents for two of it's three operating divisions. Recently the company announced the appointment of Dr. Hira L. Gurtoo, Ph.D. as President of Paracelsian's Drug Development Division.

To: Rick Costantino who wrote (4210)	3/24/1999 7:55:00 PM
From: John H. Farro	Respond to of 4342

Rick, It's great to see you back. If memory serves me right, I think AndroCar was one of the candidates they tested. This stock shot up to $2 around Feb. 4 when they announced a partnership with a yet unnamed Japanese firm to market their AhImmunoassay. It has since settled into the 1 1/4 - 1 3/8 trading range. Yesterday it closed at 27/32 and today it bounced back to 1 1/8. A few observations: Remember back in 1997 when old management announced first the postponement of the AndroVir launch in May and its cancellation in June? There was a huge volume of stock traded the day before each announcement. I am inclined to believe that somehow the word had leaked out that some bad news was about to be released. It was quite different with the news about the recent tests. Their was no spike in volume or loss in price before the news release, indicating to me that Bernie probably released the news very soon after he found out. He didn't sit on the news and try to delay the inevitable. In other words, I doubt he will try to delay bad news when this happens. Not that I want to see bad news, but this is good to know. We haven't seen any information about the Ah Immunoassay deal with Japan, but if it had fallen through I am sure it would have been announced by now. One other thing. If Monday's news had come out half a year ago it would have taken a long time for the stock price to bounce back. Indeed, if you look at the hit the company took when it got delisted you will see that the stockprice dropped much more sharply than it did yesterday. This stock is in better shape to take a hit than it was before. I think the market has greater confidence in this company than it did last October and it is more willing to forgive its temporary setbacks. We scored big time on the appointment today. I assume Reilly had Scherer's blessing to move to PRLN. I'm guessing the two company's had coordinated the move. For PRLN to attract a Vice President of his experience from such a big company is quite a coop. The extra structuring is good for the company. Now two of the three divisions have solid leadership. I hope Bernie stays with the company a good long time, but it is not healthy for the welfare of the company to remain so heavily on the shoulders of just one man. Diversifying the leadership will create greater stability. Once again, well done Bernie! Go PRLN Go! Robin